BRPI0317188A8 - novo derivado de 2,4-diamino-1,3,5-triazina - Google Patents

novo derivado de 2,4-diamino-1,3,5-triazina

Info

Publication number
BRPI0317188A8
BRPI0317188A8 BRPI0317188A BRPI0317188A BRPI0317188A8 BR PI0317188 A8 BRPI0317188 A8 BR PI0317188A8 BR PI0317188 A BRPI0317188 A BR PI0317188A BR PI0317188 A BRPI0317188 A BR PI0317188A BR PI0317188 A8 BRPI0317188 A8 BR PI0317188A8
Authority
BR
Brazil
Prior art keywords
diamino
triazine derivative
new
novel
pharmaceutically acceptable
Prior art date
Application number
BRPI0317188A
Other languages
English (en)
Inventor
Toshiko Kita
Shirou Maeda
Kanji Meguro
Original Assignee
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals Ltd filed Critical Hamari Chemicals Ltd
Publication of BRPI0317188A2 publication Critical patent/BRPI0317188A2/pt
Publication of BRPI0317188A8 publication Critical patent/BRPI0317188A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"novo derivado de 2,4-diamino-1,3,5-triazina". a presente invenção se refere a um agente antibactericida, que compreende como ingrediente ativo um composto representado pela seguinte fórmula geral (1): ou um sal farmaceuticamente aceitável do mesmo.
BRPI0317188A 2002-12-17 2003-12-16 novo derivado de 2,4-diamino-1,3,5-triazina BRPI0317188A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002365927 2002-12-17
JP2003363820 2003-10-23
PCT/JP2003/016131 WO2004054989A1 (ja) 2002-12-17 2003-12-16 新規２，４−ジアミノ−１，３，５−トリアジン誘導体

Publications (2)

Publication Number Publication Date
BRPI0317188A2 BRPI0317188A2 (pt) 2005-11-01
BRPI0317188A8 true BRPI0317188A8 (pt) 2018-05-08

Family

ID=32599275

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0317188A BRPI0317188A8 (pt) 2002-12-17 2003-12-16 novo derivado de 2,4-diamino-1,3,5-triazina

Country Status (12)

Country Link
US (1) US7622469B2 (pt)
EP (1) EP1574503B1 (pt)
JP (1) JP4391422B2 (pt)
KR (1) KR101027366B1 (pt)
AU (1) AU2003289375A1 (pt)
BR (1) BRPI0317188A8 (pt)
CA (1) CA2510468C (pt)
ES (1) ES2403141T3 (pt)
HK (1) HK1076816A1 (pt)
MX (1) MXPA05006450A (pt)
NZ (1) NZ540972A (pt)
WO (1) WO2004054989A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006018456D1 (de) * 2005-06-14 2011-01-05 Schering Corp Herstellung und verwendung von verbindungen als aspartylproteasehemmer
FR2896161B1 (fr) * 2006-01-13 2008-04-04 Merck Sante Soc Par Actions Si Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique.
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind
DE102008007314A1 (de) * 2008-02-02 2009-08-06 Merck Patent Gmbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
RS54736B1 (sr) * 2008-05-23 2016-10-31 Poxel Sas Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina
EP2332925A4 (en) * 2008-08-25 2014-03-26 Hamari Chemicals Ltd NOVEL DIHYDROTRIAZINE DERIVATIVE
EP3131877B1 (en) 2014-04-17 2023-07-19 Immunomet Therapeutics Inc. Biguanide compounds
KR102216701B1 (ko) 2014-11-20 2021-02-18 이뮤노메트테라퓨틱스 인코포레이티드 바이구아나이드 화합물 및 이의 용도
DE102018220631A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
DE102018220624A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
CN112642410A (zh) * 2020-12-01 2021-04-13 中国工程物理研究院核物理与化学研究所 一种用于水体中铀提取的抗菌聚合物纤维及其制备方法
DE102023201127A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Medizinprodukt und Verfahren zur Herstellung des Medizinprodukts
DE102023201122A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Antimikrobiell wirksames Produkt
DE102023201126A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Dihydrotriazinverbindung sowie Zusammensetzung zur Anwendung in der Podologie, bei der Prophylaxe und/oder Behandlung von Fußerkrankungen, der Behandlung von Tätowierungen und/oder Tätowierungswunden sowie der Behandlung eines Piercings und/oder von Piercing-Wunden

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168519A (en) * 1961-10-17 1965-02-02 American Cyanamid Co 1-alkylphenyl-2, 2-di lower alkyl-4, 6-diimino-hexahydro-s-triazines
US3287365A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel dihydro-s-triazines and method of preparation
US3287366A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel 1, 2-dihydro-s-triazines
DE1620178A1 (de) * 1965-12-03 1970-03-12 Ruhrchemie Ag Verfahren zur Herstellung von Aminoalkylamino-s-triazinen
JPS4541591B1 (pt) * 1967-12-11 1970-12-26
US5565451A (en) * 1994-09-15 1996-10-15 Fmc Corporation 1-substituted-2, 4-diamino-6, 6-dialkyl-1, 6-dihydro-1, 3, 5-triazines as insecticides
WO1999001442A1 (en) * 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
WO2000032580A2 (en) * 1998-12-01 2000-06-08 Nihon Bayer Agrochem K.K. Substituted 1,3,5-triazines as herbicides
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
ES2423800T3 (es) 2003-03-28 2013-09-24 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos orgánicos para la inmunopotenciación

Also Published As

Publication number Publication date
JP4391422B2 (ja) 2009-12-24
NZ540972A (en) 2009-03-31
JPWO2004054989A1 (ja) 2006-04-20
EP1574503A1 (en) 2005-09-14
ES2403141T8 (es) 2013-06-21
BRPI0317188A2 (pt) 2005-11-01
HK1076816A1 (pt) 2006-01-27
CA2510468A1 (en) 2004-07-01
KR101027366B1 (ko) 2011-04-11
KR20050085720A (ko) 2005-08-29
AU2003289375A1 (en) 2004-07-09
EP1574503A4 (en) 2008-06-25
WO2004054989A1 (ja) 2004-07-01
US7622469B2 (en) 2009-11-24
CA2510468C (en) 2011-01-04
EP1574503B1 (en) 2013-03-13
US20060154928A1 (en) 2006-07-13
MXPA05006450A (es) 2005-08-19
ES2403141T3 (es) 2013-05-14

Similar Documents

Publication Publication Date Title
HK1076816A1 (pt)
HRP20120323T1 (en) Diarylhydantoin compounds
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
BR0312729A (pt) Novos derivados de indol-3-enxofre
RS24604A (en) Herbicides containing substituted thien- 3-yl-sulfonylamino (thio)carbonyl- triazolin(thi)one
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
BR0109703A (pt) Derivados de piperazina
NO950297D0 (no) Prolinamidderivater
BR0212488A (pt) Combinações de herbicidas e protetores
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
DK1483245T3 (da) 5-substituerede alkylaminopyrazolderivater som pesticider
PL326024A1 (en) Novel derivatives of cyclodepsipeptidic substance pf1022
DE60027144D1 (de) Hydroxamsäure-derivate
RS24504A (en) Selective heribicides based on substituted thien-3-yl- sulfonylamino (thio)carbonyltriazolin (thi)ones and safeners
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
NO20070421L (no) Radiosensitiviserende middel
BR0108810A (pt) Novos agentes antibacterianos de benzosultam oxazolidinona
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
MXPA03011790A (es) Agente para la procteccion de neuronas de la retina.
DE69706950D1 (de) Furoindolizine
SE9901062D0 (sv) Use for conifer sapling protection
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL